Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism
Jim C. Hu(Presbyterian Hospital), Nancy L. Keating(Brigham and Women's Hospital), Paul L. Nguyen(Beth Israel Deaconess Medical Center), Stephen B. Williams(Cedars-Sinai Medical Center), A. James O’Malley(Dartmouth College), Matthew R. Smith(Massachusetts General Hospital)
Cited by 104
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694